repro pathology Flashcards
what is the triple test for breast cancer diagnosis?
- clinical examination
- radiology/imaging: ultrasound, mammogram
- pathology: fine needle aspiration, core biopsy, excision biopsy
acute mastitis pathogenesis and presentation
pathogenesis: cracked or inflamed nipple permits entry of microbe (s. aureus or other staphylococci) during nursing –> microbe proliferates in stagnant milk –> acute inflammation results in abscess formation
presentation: acute inflammation of the breast, erythematous red breast with concurrent fever
idiopathic granulomatous mastitis pathogenesis and presentation
pathogenesis: autoimmune disease targets secretory products of the breast - best controlled by steroids and immunosuppressants
presentation: lobulocentric granulomatous inflammation, ddx is TB
paraffinoma pathogenesis and presentation
pathogenesis: fibrosis around paraffin breast implant with foreign body-type inflammation
presentation: radiodense empty spaces surrounded by multinucleate giant cells and histiocytes
classical presentation of fibrocystic changes of the breast
• in women during reproduction decades (esp premenopausal decade)
• due to normal cyclic breast changes
• bilateral, multifocal soft lump
prognosis of fibrocystic changes of the breast
depends on the level of epithelial hyperplasia!
low: fibrosis, cystic changes, apocrine metaplasia
moderate: moderate hyperplasia, sclerosing adenosis (scar-like fibrous tissue in breast lobules)
high: atypical hyperplasia
changes involved in fibrocystic changes of the breast
non-proliferative:
cysts and apocrine metaplasia (cells have eosinophilic cytoplasm and round nuclei)
proliferative:
epithelial hyperplasia, fibrosis, (sclerosing) adenosis –> hard rubbery lump may be mistaken for breast cancer
fibroadenoma pathogenesis and presentation
pathogenesis: pleomorphic lesion of fibrous and glandular tissue
presentation:
- young women (25yo)
- MOUSE IN THE BREAST!!! firm well-defined slow-growing mobile tumour (1-6cm)
- tan white colour with yellowish specks
- glandular and stromal elements
- circumscribed and uniform
phyllodes tumour pathogenesis and presentation
pathogenesis: fibroepithelial tumour from intralobular stroma
presentation:
- presents in young women (25yo)
- risk of malignancy due to proliferating stromal elements (EXCISE A LARGE MARGIN)
- leaf like pattern = benign, stromal proliferation = malignant
- haematogenous metastasis to the lungs
- possible necrosis and/or haemorrhage
papilloma pathogenesis and presentation
pathogenesis: benign neoplastic papillary growth
presentation:
- premenopausal women
- commonly causes bloody nipple discharge
- solitary lesions/lumps but too small to see on mammogram
- necrosis of tips of papillae may cause haemorrhage, bloody nipple discharge, nipple retraction
risk factors for breast carcinoma
rich, obese, premenopausal woman who is Caucasian, Jew or Parsi with previous breast disease, who has never had children and doesn’t breastfeed, takes hormones, loves radioactive material, has positive family history (BRCA1, BRCA2, p53, PTEN genes) who had early menarche and will have late menopause
presentation of breast carcinoma
- palpable mass that is scirrhous, encephaloid or mucinous
- most commonly in upper outer quadrant > subareolar > others
- nipple discharge and retraction or Paget’s disease (erosion and redness)
- mammographic density and calcifications
- peau d’ orange appearance (tethered skin due to Cooper ligaments)
- lymph node metastases (esp palpable axillary nodes)
ductal carcinoma in situ presentation
- mammographic density, nipple discharge, Paget’s disease, palpable mass
- found in ducts (duh)
- medium or large sized cells with varied histological types (comedo, cribriform, solid, papillary, micropapillary)
- higher chance of malignant change and E-cadherin expression
- possible necrosis
lobular carcinoma in situ presentation
- incidental finding, not really any symptoms
- found in lobules (duh)
- small cells with solid histology
- low chance of malignant change
- may express ER, PR or HER2 receptors
Paget’s disease pathogenesis and presentation
pathogenesis: extension of DCIS along ducts in the epithelial layer to the nipple skin
presentation: eczematous scaly crusting/erosion/redness on the nipple unilaterally, causing ulceration of the nipple also
invasive ductal carcinoma presentation
desmoplastic change replacing normal breast fat and forming a firm palpable mass with an irregular border
invasive lobular carcinoma presentation
tumour cells invade stroma in a linear pattern forming strands (single file) with a loss of cellular adhesion, cells are E-cadherin negative
mucinous carcinoma presentation
rubbery soft tumour on a mucinous background, low grade and good prognosis tumour
medullary carcinoma presentation
high grade, poorly differentiated and well circumscribed tumour that initiates extensive lymphoplasmacytic/immune response and responds well to chemotherapy
no special type carcinoma presentation
indistinct tumour morphology but the most common type of breast carcinoma, basically for any tumour that doesn’t fit the others
causes of gynaecomastia
drug-induced, testicular atrophy, liver cirrhosis, estrogen-secreting tumours (testis, adrenal gland etc), hyperprolactinemia, hormonal imbalances from puberty
TNM staging of breast cancer
T: primary tumour (1-4)
N: lymphatic spread (0-3)
M: distant metastases (x, 0-1)
grading factors of breast cancer
histological grades (1-3) based on:
1. tubule formation
2. nuclear pleomorphism
3. mitotic count
benign prostatic hyperplasia pathogenesis
testosterone is converted into DHT by 5α-reductase and binds to androgen receptors on prostatic cells to produce growth factors (growth rate>death rate), leading to progressive hyperplasia of stromal and epithelial prostate cells especially in transitional zone
diagnosis of benign prostatic hyperplasia
- digital rectal examination for enlarged prostate
- ultrasound of testicles, prostate, kidney, bladder for associated pathologies
- prostate-specific antigen amt elevation
presentation of benign prostatic hyperplasia
- storage: increased frequency and urgency of urination, nocturia
- voiding: hesitancy or intermittent interruption of urine stream
- urinary tract obstruction: bladder distention and hypertrophy, hydronephrosis, urinary tract infections –> pyelonephritis
- urolithiasis and CKD
treatment for benign prostatic hyperplasia
- transurethral resection of the prostate
- α-blockers (Prazosin, Tamulosin) to relax the smooth muscle in the prostate and bladder neck
- lower fluid, alcohol and caffeine intake
prostatic cancer presentation
- asymptomatic
- urinary symptoms, similar to BPH
- back pain and other symptoms of metastases
- constitutional symptoms
- enlarged, hard, bumpy prostate gland on DRE
- elevated serum prostate specific antigen levels
pathogenesis of prostatic carcinoma
- usually found in acinar cells (95%) but may also be found in ductal cells
- in the peripheral zone of the prostate
- infiltrative malignant glands with nuclear atypia and absent basal cell layers
what is the Gleason grading?
grading for prostate cancer based on architecture of the two most undifferentiated/malignant looking parts of the prostate, can go up to 12
treatment for prostatic carcinoma
- radical prostatectomy for localised disease
- radiotherapy for localised/locally advanced disease
- androgen deprivation therapy for advanced/metastatic disease
condyloma acuminatum pathology and presentation
pathology: sexually transmitted via HPV 6/8
presentation: benign tumour on the inner surface of the prepuce, can be sessile/pedunculated
histologically: branching papillary stroma, covered by epithelium with superficial hyperkeratosis and acanthosis, enlarged and irregular hyperchromatic nuclei with perinuclear haloes